NICORETTE MICROTAB nicotine 2mg sublingual tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

nicotine betadex complex, Quantity: 17.1 mg (Equivalent: nicotine, Qty 2 mg)

Commercializzato da:

Johnson & Johnson Pacific Pty Ltd

Forma farmaceutica:

Tablet, uncoated

Composizione:

Excipient Ingredients: betadex; magnesium stearate; crospovidone; colloidal anhydrous silica

Via di somministrazione:

Sublingual

Confezione:

100, 30

Tipo di ricetta:

Not Scheduled after consideration by Committee

Indicazioni terapeutiche:

For the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus facilitating smoking cessation in smokers motivated to quit.

Dettagli prodotto:

Visual Identification: A white to off-white flat round bevel-edged tablet with a diameter of 6mm, engraved "Nic" on one side and "2" on the opposite side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2001-11-27